Choice Is Good at Times: The Emergence of [⁶⁴Cu]Cu-DOTATATE-Based Somatostatin Receptor Imaging in the Era of [⁶⁸Ga]Ga-DOTATATE

J Nucl Med. 2022 Sep;63(9):1300-1301. doi: 10.2967/jnumed.122.264183. Epub 2022 May 26.

Authors

Affiliations

¹ National Institutes of Health, Bethesda, Maryland.
² Tufts University School of Medicine, Boston, Massachusetts.
³ University of California, San Francisco, California.
⁴ La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France; and.
⁵ Johns Hopkins Medicine, Baltimore, Maryland.
⁶ National Institutes of Health, Bethesda, Maryland; karel@mail.nih.gov.

No abstract available

Publication types

Research Support, N.I.H., Intramural

MeSH terms

Gallium Radioisotopes
Humans
Neuroendocrine Tumors* / diagnostic imaging
Organometallic Compounds*
Positron Emission Tomography Computed Tomography / methods
Positron-Emission Tomography
Radionuclide Imaging
Radiopharmaceuticals
Receptors, Somatostatin

Substances

Gallium Radioisotopes
Organometallic Compounds
Radiopharmaceuticals
Receptors, Somatostatin
copper dotatate CU-64